We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions

By LabMedica International staff writers
Posted on 15 Nov 2011
In a move set to boost growth with a local presence in India, Leica Microsystems (Wetzlar, Germany) acquired the microscopy and histopathology divisions of Labindia Instruments Pvt. More...
Ltd. (Thane, India).

This move comes after more than 20 years during which Labindia has successfully distributed Leica’s products in India. Over 130 associates from Labindia have transferred to Leica Microsystems to sustain continuity for existing customers who will continue to benefit from Labindia’s experience of their needs and applications. The acquisition is the culmination of a long partnership, and supports Leica Microsystems’ strategy to expand its operations in India.

“Leica Microsystems’ expansion of its commercial operations in India creates extended opportunities for interaction, collaboration, and innovation to benefit all of our customers in the life sciences, industrial laboratories and hospitals for both diagnostics and surgery,” explains Arnd Kaldowski, president Leica Microsystems. “This acquisition will enable closer contact with our customers so that we can better support them in their day-to-day work.”

Vijay Bibikar, director Labindia, commented, “We are convinced that at this point in time this agreement is a logical further step in the long history of close cooperation between Labindia and Leica Microsystems and that it will be beneficial to all our customers.” Says Kaldowski: “We highly appreciate the work that our partner Labindia has done driving our business in India to its present high level. We are excited about the future potential of the Indian market and the potential to help our customers to meet with their professional challenges.”

Leica Microsystems is a world leader in microscopes and scientific instruments. Leica Microsystems is organized in four divisions: the Life Science Division, Industry Division, Biosystems Division, and Medical Division. Leica Microsystems’ Biosystems Division, also known as Leica Biosystems offers histopathology laboratories a product range for each step in histology and for high levels of productivity in the working processes. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers.

Related Links:
Leica Microsystems
Labindia Instruments


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.